ABN AMRO Fund

In 1991 was created ABN AMRO Fund, which is appeared as VC. The fund was located in Europe if to be more exact in The Netherlands. ABN AMRO Fund appeared to be a CVC structure as part of the corporation. The main office of represented VC is situated in the Amsterdam.

The top amount of exits for fund were in 2009. Comparing to the other companies, this ABN AMRO Fund performs on 14 percentage points more the average number of lead investments. When the investment is from ABN AMRO Fund the average startup value is 10-50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2000. Speaking about the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations.

The fund was created by Bernard-Louis Roques.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the ABN AMRO Fund, startups are often financed by St. Paul Venture Capital, Granite Ventures, West Deutsche Landesbank Girozentrale. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital. In the next rounds fund is usually obtained by Forbion Capital Partners, Scottish Equity Partners, Oxford Bioscience Partners.

Among the most popular portfolio startups of the fund, we may highlight Cortera, AM Pharma, BioVex. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Biotechnology, Information Technology.

Notable deals

Review

• No reviews are submitted yet.